Steve Harvey, MD, discusses the challenges of defining treatment resistant depression and provides and overview of treatment options.
Back
Treatment Resistant Depression
Experts share clinical perspective and practical insights regarding current challenges and opportunities in the management of patients with treatment-resistant depression, in highlights from a recent State of the Science SummitTM, presented by HCP Live®
Treatment Resistant Depression
Episodes
All
All
William M. Sauve, MD, reviews the landscape of delivery mechanisms for ketamine agents, including intravenous, sublingual, and intramuscular.
Hanita Chhabra, MD, highlights safety and efficacy data of esketamine and shares practical implications for clinical practice.
Geoffrey Grammer, MD, offers guidance on navigating challenges such as elevated blood pressure and substance misuse and abuse regarding the use of esketamine.
Advertisement
Advertisement
Trending on HCPLive
1
Alpha-Gal Syndrome: Closing an Underrecognized Allergy Diagnostic Gap
2
Pelacarsen Misses Primary Endpoint in Lp(a)HORIZON Phase 3 Trial
3
GRI-0621 Improves FVC, Reduces Fibrotic Biomarkers in IPF
4
ORFAN-MAESTRIA: AI Predicts Cardioembolic Stroke, Atrial Fibrillation from CT Scans
5